Pulse Pressure Variability With Position Before EPIdural Analgesia
PP-PERI
Predictive Value of a Postural Test on Pulse Pressure Variation During Labor With Epidural Analgesia on Fetal Heart Rate Abnormalities
2 other identifiers
interventional
1
1 country
4
Brief Summary
Fetal heart rate abnormalities are common. Miller et al. have demonstrated that new onset fetal heart rate abnormalities after initial labor epidural dosing occur more frequently in women with a low admission pulse pressure than those with a normal admission pulse. The aim of the present study is to look for a statistical link between the occurrence of a fetal heart abnormality requiring an intervention and maternal hemodynamic factors (blood pressure, pulse pressure, and cardiac output) measured before epidural analgesia in two positions: dorsal decubitus position and in the left lateral decubitus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2018
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2017
CompletedFirst Posted
Study publicly available on registry
April 24, 2017
CompletedStudy Start
First participant enrolled
December 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedAugust 3, 2022
August 1, 2022
3.1 years
March 21, 2017
August 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fetal heart rate
Fetal heart rate abnormalities occurring during the first hour of epidural analgesia and requiring an intervention. Relationship between maternal hemodynamic factors (heart rate, blood pressure, pulse pressure, and cardiac output) measured before epidural analgesia in two positions (dorsal decubitus position and in the left lateral decubitus) and fetal heart rate abnormalities occurring during the first hour of epidural analgesia and requiring an intervention.
4 days
Secondary Outcomes (4)
Fetal heart rate
4 days
Mode of delivery
4 days
Newborn heart rate, blood pressure, pulse pressure, and cardiac output
4 days
Number of patients with hemodynamic abnormalities
4 days
Study Arms (1)
Pregnant women
EXPERIMENTALInterventions
Heart rate, arterial pressure and cardiac output measurements (monitor NICOM) performed in the dorsal decubitus position and in the left lateral decubitus
Eligibility Criteria
You may qualify if:
- pregnant women
- gestational age ≥ 36 weeks
- single eutrophic fetus
- wishing for epidural analgesia
- cervical dilatation less than or equal to 5 cm
- spontaneous labor
- scheduled for a vaginal delivery.
- prematurity (\< 36 weeks of amenorrhea) or post-term birth
- intention of induction of labour using oxytocin before epidural analgesia or prostaglandin
- contraindication to epidural analgesia
- history of hypertension or gravidic hypertension or heart disorder
- gestational diabetes
- foetal malformation or oligohydramnios or fetal growth abnormality
- fœtal macrosomia diagnosed by ultrasonic scanning
- hematocrit less than 20%
You may not qualify if:
- induction of labour using oxytocin before epidural analgesia
- newborn weight \> 4kg at birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hopital Fochlead
Study Sites (4)
AP-HP Hopital Antoine Beclere
Clamart, 92140, France
Institut Hospitalier Franco-Britannique
Levallois-Perret, 92300, France
Institut Mutualiste Montsouris
Paris, 75014, France
Hopital Foch
Suresnes, 92150, France
Related Publications (1)
Miller NR, Cypher RL, Nielsen PE, Foglia LM. Maternal pulse pressure at admission is a risk factor for fetal heart rate changes after initial dosing of a labor epidural: a retrospective cohort study. Am J Obstet Gynecol. 2013 Oct;209(4):382.e1-8. doi: 10.1016/j.ajog.2013.05.049. Epub 2013 Jun 13.
PMID: 23769849BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Morgan Le Guen, MD
Hôpital Foch
- STUDY CHAIR
Marc Fischler, MD PhD
Hôpital Foch
- STUDY CHAIR
Frédéric Mercier, MD PhD
AP-HP Hôpital A. Béclère
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2017
First Posted
April 24, 2017
Study Start
December 12, 2018
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
August 3, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share